Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
The original revenue from the NHS was upgraded long ago from £5m to £8m. People subtly trying to deramp lol!
If all babies admitted to NICUs receive Genedrive like they already are in Brighton then revenues will be vastly more.
Guy, Eureka is not saying every baby being born he (and the document) is saying every baby admitted to the unit. So all unwell babies at Brighton are receiving the test so they are ready for antibiotics if needed. I understand most will need antibiotics however it is clear that they are giving the test to all babies to be safe.
I believe James is pushing specialist commissioning through which circumvents the need for NICE full recommendation.
Roger, why are you assuming this? “ Assuming it’s just the preterm babies given the test it’s £2.4m per year.”
It’s always been all babies needing antibiotics will receive the test (not only preteen babies) which is £8m per year.
Yes what’s happening in Brighton suggests all babies admitted to the unit will now receive the test, which makes total sense and increases revenues to £24m per year for the uk alone.
There was a comment on LinkedIn last week saying that Genedrive is going to be rolled out across the whole KSS (Kent, Surrey, Sussex) area in Q1 which presumably will include the other Brighton area units.
Fantastic find Rud! I understood the financial modelling was based on testing babies who were going to be given antibiotics. If this is the case and it becomes common practice to test all babies when they are admitted to a unit then revenues will surely be significantly higher than previous estimates.
We’re not obligated to take all the drawdowns. At the moment we’re issuing lots more shares just to keep the facility going as we’re below 16p. We could stop that if we no longer needed it.
RF would only be able to request shares if they have a shortfall then, or when the share price is higher if they take up their warrants… which will bring in even more money to Genedrive.
If we hear news that specialist commissioning is happening, we won’t need Riverfort anymore as money will be flowing in with full NHS rollout.
RF sells are nothing to worry about, they're just doing what they do as part of their business plan, they simply sell when when there is enough volume to do so. The 1 million trade though is without a doubt a buy and far more interesting.
The 2m will be Riverfort, but the 1m was clearly a buy so somebody taking a large position.
How it's stated is simply down to what the ask and bid is at the time the trade is listed, it's automatic. The trade at 8.5 was right in the middle of the bid and ask at the time the trade was listed so the system marks it as unknown, however it was stated that the trade was from 1 hour earlier, when the ask was 8.5 so at that time it would have been shown as a buy.
Also it has not been possible to sell at 8.5 at any time today yet lol, so safe to say it was a buy.
It wasn’t possible to sell at that price at or before the delayed time, that was the asking price so definitely a buy.
That's what I"m thinking system, I think to have rollout across the whole KSS might suggest that specialist commissioning is about to happen.
Nice
It'll be RNSd when it goes live I imagine, similar to Brighton.
Excellent news!
“ Genedrive MT-RNR1 System to be rolled out across KSS in QI project led by my colleague Dr. Aung Soe, discussed further today at Network Governance Forum.”
Genedrive can make a drawdown regardless of volume, it makes no difference.
JC said they were finalising agreements with some really good FDA partners who will help get AIHL through the FDA process faster and much cheaper than would usually be expected. He said he expects to update us on this by end of January.
He also said something is going to happen in January regarding NICE and AIHL. Plus stroke marker guidance report published this month hopefully.
Another big one is specialist commission which will allow us to circumvent NICE and immediately begin full rollout to the NHS. This is expected to happen sooner rather than later.
With the news expected this month, there’s an opportunity for 40-100% profit from this level imo. Sucker if you miss it imo lol. Good luck all.
I expect we’ll get some more of the expected positive news before any funding. After all the amount they’ll need will depend on the deal with the partners, so I expect partner news to come first, as well as NICE update for stroke marker test and special commissioning for AIHL.